51 related articles for article (PubMed ID: 27075381)
1. Long-term follow-up of non-myasthenic patients with early-stage thymoma who underwent extended thymectomy or limited resection.
Tsai PC; Tseng YC; Ting YC; Huang CS; Hsu WH; Tang EK; Hsu HS
Eur J Surg Oncol; 2024 Jun; 50(6):108349. PubMed ID: 38640605
[TBL] [Abstract][Full Text] [Related]
2. The rate of QMGS change predicts recurrence after thymectomy in myasthenia gravis.
Liu X; Li R; Li W; Liu W; Wang J; Jing Y
J Clin Neurosci; 2024 Jun; 124():20-26. PubMed ID: 38640804
[TBL] [Abstract][Full Text] [Related]
3. Randomized Trial of Thymectomy in Myasthenia Gravis.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia gravis - autoantibody characteristics and their implications for therapy.
Gilhus NE; Skeie GO; Romi F; Lazaridis K; Zisimopoulou P; Tzartos S
Nat Rev Neurol; 2016 May; 12(5):259-68. PubMed ID: 27103470
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
Zekeridou A; McKeon A; Lennon VA
JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma.
Song Y; Zhou L; Miao F; Chen G; Zhu Y; Gao X; Wang Y; Pang L; Zhao C; Sun X; Chen Z
J Thorac Dis; 2016 Mar; 8(3):314-22. PubMed ID: 27076925
[TBL] [Abstract][Full Text] [Related]
7. MG-QoL-15 scores in treated myasthenia gravis: Experience from a university hospital in India.
Kumar R; Nagappa M; Sinha S; Taly AB; Rao S
Neurol India; 2016; 64(3):405-10. PubMed ID: 27147146
[TBL] [Abstract][Full Text] [Related]
8. Single fiber EMG as a prognostic tool in myasthenia gravis.
Baruca M; Leonardis L; Podnar S; Hojs-Fabjan T; Grad A; Jerin A; Blagus R; Šega-Jazbec S
Muscle Nerve; 2016 Dec; 54(6):1034-1040. PubMed ID: 27144873
[TBL] [Abstract][Full Text] [Related]
9. Pemphigus foliaceus exacerbated by radiation, in association with myasthenia gravis.
Liebman TN; Lieberman MR; Burris K
Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136623
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis with muscle specific kinase antibodies mimicking amyotrophic lateral sclerosis.
Huijbers MG; Niks EH; Klooster R; de Visser M; Kuks JB; Veldink JH; Klarenbeek P; Van Damme P; de Baets MH; van der Maarel SM; van den Berg LH; Verschuuren JJ
Neuromuscul Disord; 2016 Jun; 26(6):350-3. PubMed ID: 27133662
[TBL] [Abstract][Full Text] [Related]
11. B-cell-activating factor is elevated in serum of patients with myasthenia gravis.
Kang SY; Kang CH; Lee KH
Muscle Nerve; 2016 Dec; 54(6):1030-1033. PubMed ID: 27121160
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis of 241 thymic epithelial tumors-experience in the Shanghai Chest Hospital from 1997-2004.
Zhu L; Zhang J; Marx A; Weiss C; Fang WT
J Thorac Dis; 2016 Apr; 8(4):718-26. PubMed ID: 27114840
[TBL] [Abstract][Full Text] [Related]
13. Statins and Myasthenia Gravis.
Khalid R; Ibad A; Thompson PD
Muscle Nerve; 2016 Sep; 54(3):509. PubMed ID: 27105400
[No Abstract] [Full Text] [Related]
14. Subcostal thoracoscopic extended thymectomy for patients with myasthenia gravis.
Tang Y; Ou ZA; Liao M; Xuan Y; Su K; Xu EW; Xiao H; Peng X; Zhang Z; Liu Y; Qiao GB
J Thorac Dis; 2016 Mar; 8(3):499-504. PubMed ID: 27076946
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients.
Wiboonpong P; Setthawatcharawanich S; Korathanakhun P; Amornpojnimman T; Pruphetkaew N; Chongphattararot P; Sathirapanya C; Sathirapanya P
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833734
[TBL] [Abstract][Full Text] [Related]
16. Importance of thymectomy and prognostic factors in the complex treatment of myasthenia gravis.
Bak V; Spalek P; Rajcok M; Danihel L; Schnorrer M
Bratisl Lek Listy; 2016; 117(4):195-200. PubMed ID: 27075381
[TBL] [Abstract][Full Text] [Related]
17. Thymectomy for Myasthenia Gravis: Complete Stable Remission and Associated Prognostic Factors in Over 1000 Cases.
Kaufman AJ; Palatt J; Sivak M; Raimondi P; Lee DS; Wolf A; Lajam F; Bhora F; Flores RM
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):561-568. PubMed ID: 28043477
[TBL] [Abstract][Full Text] [Related]
18. Modified maximal thymectomy for thymic epithelial tumors: predictors of survival and neurological outcome in patients with thymomatous myasthenia gravis.
Prokakis C; Koletsis E; Apostolakis E; Zolota V; Chroni E; Baltayiannis N; Chatzimichalis A; Dougenis D
World J Surg; 2009 Aug; 33(8):1650-8. PubMed ID: 19506940
[TBL] [Abstract][Full Text] [Related]
19. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment.
Lucchi M; Ricciardi R; Melfi F; Duranti L; Basolo F; Palmiero G; Murri L; Mussi A
Eur J Cardiothorac Surg; 2009 May; 35(5):812-6; discussion 816. PubMed ID: 19237289
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
